Clinical Trial

Effect of Prednisone and Aspirin on IVF-ET Outcome Among Patients With Thyroid Autoimmunity

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated October 13, 2022 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This trial was a 1:1 (active:placebo) randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of prednisone and aspirin for the in vitro fertilization and embryo transfer outcome among patients with thyroid autoimmunity.
Protocol Amendment History 1 change
notable Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University -> Second Affiliated Hospital, Zhejiang University, School of Medicine 2026-08-09
Trial Details
NCT Number NCT05578456
Lead Sponsor Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborators: Ningbo Women & Children's Hospital, Jinhua People's Hospital, Jiaxing Maternity and Child Health Care Hospital
Conditions Thyroiditis, Autoimmune, Infertility
Enrollment 540 participants
Start Date 2022-11-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2022-10-13